Visión generalGráficoNoticiasTraderScreen

BNP Paribas Put 550 LONN 19.12.20.../  DE000PC6N1T5  /

Frankfurt Zert./BNP
08/11/2024  16:21:02 Diferencia0.000 Bid16:21:22 Ask16:21:22 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
0.710EUR 0.00% -
Volumen de oferta: -		 -
Tamaño/ Volumen/ Formato de Ask: -		 LONZA N 550.00 CHF 19/12/2025 Put
GlobeNewswire 26/08 Simtra BioPharma Solutions Appoints Dr. Lidia Serina as Head of Development Sciences
GlobeNewswire 23/08 Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, G...
GlobeNewswire 08/08 Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 06/08 Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 14/06 Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
GlobeNewswire 13/06 Repligen Announces CEO Transition Plan
GlobeNewswire 30/05 Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire 15/05 Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire 08/05 Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 Maravai LifeSciences Reports First Quarter 2024 Financial Results
GlobeNewswire 04/04 Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire 04/04 Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire 27/02 Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 15/02 Galapagos presents at EBMT-EHA annual meeting 2024
GlobeNewswire 04/01 Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire 19/12/2023 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire 09/12/2023 Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire 07/12/2023 Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire 07/12/2023 Business Update
GlobeNewswire 06/11/2023 Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 01/11/2023 Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
GlobeNewswire 19/10/2023 Viralgen welcomes back Andy Holt as CCO
GlobeNewswire 16/10/2023 Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire 02/10/2023 Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire 20/09/2023 Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023